Looking to publish in Advances in Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginAdvances in Therapy is an international, hybrid, peer-reviewed single-blind journal covering therapies, devices, and surgical techniques across all therapy areas. It emphasizes rapid publication, broad inclusion of scientifically sound research including positive, confirmatory, and negative data, and accepts work from clinical phase, real-world, and health economics outcomes studies for both international and country-specific audiences.
Looking to publish in Advances in Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Advances in Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Narrative Review
Systemic Review
Brief Reports
Case Series
Guidelines
Letters To The Editor
Recent Publications
Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications
M. Farris Sawaya, Molly E. McNulty, Collin J. St. Germain, Ibraheem A. Hachem, Meissy S. Calix, Rhys M. Lormand, Nicholas J. E. McComb, Abdallah A. Abu Shehab, James Wrightson, Ahmed I. Anwar, Cy J. Fontenot, Alan D. Kaye, Kevin S. Murnane
Design of a New Predictive Equation for the Induction Dose of Tacrolimus in Immediate Renal Transplantation
Olga Guillén-Martínez, Enrique Barrajón-Catalán, Daniel Martínez-Caballero Martínez, Leticia Soriano-Irigaray, Fernando Borrás-Rocher, Leonidas Cruzado-Vega, Alejandra Sabater-Belmar, Ana Cristina Murcia-López
Comparative Cost-Effectiveness of Advanced Treatment Sequences for Moderately to Severely Active Ulcerative Colitis in Japan
Kazumasa Kamei, Miwa Enami, Hiroyuki Matsuda, Katsuya Yamagami, Yawen Dai, Masato Hoshi, Ernest H. Law, Akira Yuasa
Effectiveness and Safety of Nefecon in Primary IgA Nephropathy Across Different Baseline Proteinuria Levels: A Real-World Study
Chahan Suolinge, Cai Dema, Xinyue Wu, Bijian Jiang, Chen Lu, Jing Li
Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis
Lytske J. Bakker, Katharina Nickel, Zoe Cheah, Elizabeth A. Sigworth, Bodille P. M. Blomaard, Reginald Villacorta, Lixian Jin, Kiran Davé, Claire L. Simons, Craig Bennison
Frequently asked questions
How long does it take to publish?
The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online, and reports a median of 2 days from submission to first decision.
Reformat to Advances in Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC: £3090.00 GBP / $4990.00 USD / €3990.00 EUR. Subscription publishing: no APC.
Reformat to Advances in Therapy using Livewrite Premium